Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity Note

v2.4.0.8
Stockholders' Equity Note
12 Months Ended
Dec. 31, 2013
Notes  
Stockholders' Equity Note

7.  STOCKHOLDERS’ EQUITY

 

Common Stock - The Company has authorized 20,000,000 common shares with a $0.0001 par value. There were 8,082,000 and 1,900,000 shares issued and outstanding at December 31, 2013 and December 31, 2012, respectively.

 

Preferred Stock - The Company has authorized 4,500,000 shares of Preferred Stock with a $0.0001 par value.  As holders of any series of preferred stock convert into common shares the preferred shares are no longer outstanding and become available for reissuance.  As of December 31, 2013 and 2012, there were 1,005,648 and 2,860,000 preferred shares outstanding, respectively.

 

Series A Preferred Stock - As of December 31, 2013 there were no shares of Series A Preferred Stock outstanding and 600,000 shares outstanding as of December 31, 2012.

 

During the year ended December 31, 2013; 600,000 Series A preferred shares were converted to common shares at a ratio of 7:1.  The Series A Preferred Stock ranked senior in liquidation and dividend preferences to the Company’s common stock. Holders of Series A Preferred Stock accrued dividends at the rate per annum of $0.066664. Dividends on Series A preferred shares are paid only upon liquidation, therefore the conversion of Series A preferred shares to common shares resulted in a full release of the accumulated dividends as of December 31, 2013.

 

Series B Preferred Stock - As of December 31, 2013 there were 177,000 shares of Series B Preferred Stock outstanding and 1,500,000 shares outstanding as of December 31, 2012.

 

During the year ended December 31, 2013; 1,323,000 Series B preferred shares were converted to common shares.  The Series B Preferred Stock ranks senior in liquidation and dividend preferences to the Company’s common stock. Holders of Series B Preferred Stock accrue dividends at the rate per annum of $0.16 per share. Dividends on Series B preferred shares are paid only upon liquidation, therefore the conversion of Series B preferred shares to common shares resulted in a release of $361,426 in accumulated dividends during the year ended December 31, 2013. At December 31, 2013 and 2012, Series B Preferred Stock had dividends accumulated of $62,227 and $286,685. No dividends have been declared, therefore there are no amounts accrued on the balance sheet.

 

The holders of the Series B Preferred Stock have conversion rights equivalent to such number of fully paid and non-assessable shares of common stock as is determined by dividing the Series B original issue price of $2.00 by the then applicable conversion price. The conversion ratio is subject to customary anti-dilution adjustments, including in the event that the Company issues equity securities at a price equivalent to or less than the conversion price in effect immediately prior to such issue.

 

The holders of Series B Preferred Stock have a liquidation preference over the holders of the Company’s common stock equivalent to the purchase price per share of the Series B Preferred Stock plus any accrued and unpaid dividends, whether or not declared, on the Series B Preferred Stock. A liquidation would be deemed to occur upon the happening of customary events, including transfer of all or substantially all of the Company’s common stock or assets or a merger, or consolidation. The Company believes that such liquidation events are within its control and therefore the Company has classified the Series B Preferred Stock in stockholders’ equity.

 

The holders of Series B Preferred Stock vote together as a single class with the holders of the Company’s common stock on all action to be taken by the Company’s stockholders. Each share of Series B Preferred Stock entitles the holder to the number of votes equal to the number of shares of common stock into which the shares of the Series B Preferred Stock are convertible as of the record date for determining stockholders entitled to vote on such matter.

 

Series C Preferred Stock - As of December 31, 2013 there were 101,000 shares of Series C Preferred Stock outstanding and 760,000 shares outstanding as of December 31, 2012.

 

During the year ended December 31, 2013; 659,000 Series C preferred shares were converted to common shares. The Series C Preferred Stock ranks senior in liquidation and dividend preferences to the Company’s common stock. Holders of Series C Preferred Stock accrue dividends at the rate per annum of $0.16 per share. At December 31, 2013, Series C Preferred Stock had dividends accumulated of $118,268. Dividends of $95,600 were paid upon the conversion of Series C preferred shares to common shares.  As dividends are accrued and payable quarterly on the Series C Preferred Stock, the Company had dividends payable of $22,668 and $49,172 included in accrued expenses as of December 31, 2013 and 2012, respectively.

 

The holders of the Series C Preferred Stock have conversion rights equivalent to such number of fully paid and non-assessable shares of common stock as is determined by dividing the Series C original issue price of $2.00 by the then applicable conversion price. The conversion ratio is subject to customary anti-dilution adjustments, including in the event that the Company issues equity securities at a price equivalent to or less than the conversion price in effect immediately prior to such issue.

 

The holders of Series C Preferred Stock have a liquidation preference over the holders of the Company’s common stock equivalent to the purchase price per share of the Series C Preferred Stock plus any accrued and unpaid dividends, whether or not declared, on the Series C Preferred Stock. A liquidation would be deemed to occur upon the happening of customary events, including transfer of all or substantially all of the Company’s common stock or assets or a merger, or consolidation. The Company believes that such liquidation events are within its control and therefore the Company has classified the Series C Preferred Stock in stockholders’ equity.

 

The holders of Series C Preferred Stock vote together as a single class with the holders of the Company’s common stock on all action to be taken by the Company’s stockholders. Each share of Series C Preferred Stock entitles the holder to the number of votes equal to the number of shares of common stock into which the shares of the Series C Preferred Stock are convertible as of the record date for determining stockholders entitled to vote on such matter.

 

Series D Preferred Stock - As of December 31, 2013 there were 727,648 shares of Series D Preferred Stock outstanding and no shares outstanding as of December 21, 2012.

 

On June 21, 2013, the Company offered 1,500,000 units at $3.00 per unit for potential total proceeds of $4,500,000.  On August 30, 2013, the Company completed its offering with a total of 727,648 units sold at $3.00 per unit for gross proceeds of $2,182,944, which consisted of $1,432,962 in cash and $749,982 in a non-cash conversion of senior secured notes payable.  The Company paid share issuance costs in the amount of $84,232. Each unit consisted of one share of Series D Preferred Stock and one-half warrant, with each whole warrant exercisable at $3.00 per share.

 

Holders of Series D Preferred Stock accrue dividends at the rate per annum of $0.24 per share, payable on a quarterly basis. As dividends are accrued and payable quarterly on the Series D Preferred Stock, the Company paid dividends of $24,407 during the year ended December 31, 2013.  As of December 31, 2013 the Company has dividends payable in accrued expenses of $44,018.

 

The holders of the Series D Preferred Stock have conversion rights equivalent to such number of fully paid and non-assessable shares of common stock as is determined by dividing the Series D original issue price of $3.00 by the then applicable conversion price. Each Series D Share will convert into one share of our common stock at any time at the option of the holder of the Series D Shares or will be converted at the option of the Company at any time the trading price of our common stock is at least $4.50 per share for ten consecutive trading days. The conversion ratio is subject to anti-dilution adjustments, including in the event that the Company issues equity securities at a price equivalent to or less than the conversion price in effect immediately prior to such issue. We have determined that there is a beneficial conversion feature (“BCF”). The calculated value as of the commitment date of the BCF was $176,729, which represents the difference between the effective conversion price and the stated conversion price multiplied by the total number of shares which may be converted. We have recorded this amount as a deemed dividend as of the date of issuance, August 30, 2013, as the Series D Preferred Stock is immediately convertible. This amount was recorded as a charge against our accumulated deficit in our accompanying balance sheet.

 

The holders of Series D Preferred Stock have a liquidation preference over the holders of the Company’s common stock equivalent to the purchase price per share of the Series D Preferred Stock plus any accrued and unpaid dividends, whether or not declared, on the Series D Preferred Stock. A liquidation would be deemed to occur upon the happening of customary events, including transfer of all or substantially all of the Company’s common stock or assets or a merger, or consolidation. The Company believes that such liquidation events are within its control and therefore the Company has classified the Series D Preferred Stock in stockholders’ equity.

 

The holders of Series D Preferred Stock vote together as a single class with the holders of the Company’s common stock on all action to be taken by the Company’s stockholders. Each share of Series D Preferred Stock entitles the holder to the number of votes equal to the number of shares of common stock into which the shares of the Series D Preferred Stock are convertible as of the record date for determining stockholders entitled to vote on such matter.

 

Each unit includes one-half warrant.  Each full warrant grants the right to purchase a share of the Company’s common stock and, as of December 31, 2013, there were warrants to purchase 363,824 shares of common stock outstanding.  The warrants will be exercisable by the holders at any time on or after the issuance date of the warrants through and including October 1, 2014.

 

In October 2013, the Company initiated a follow-on Series D Preferred stock offering to sell the remaining 772,352 units at $3.00 per unit for up to $2,317,056 gross proceeds. The offering includes an over-allotment of 1,000,000 units for an additional $3,000,000 in potential gross proceeds.  The offering term ends March 31, 2014, unless we extend the offering for a period not to exceed 60 additional days which would allow us to extend the offering through May 30, 2014.

 

The terms of the follow-on Series D preferred stock offering are the same as the original Series D preferred stock offering except that the warrants will be exercisable by the holders at any time on or after the issuance date of the warrants through and including one year from their respective issuance dates.  In addition, the Company agreed to use its best efforts to register the shares underlying the warrants issued in the follow-on Series D preferred stock offering and the original Series D preferred stock offering.  The Company intends to file the registration statement not later than 90 days following the completion of the offering and will use its best efforts to maintain the effectiveness of the registration statement for the investors in this and the prior offering through December 31, 2015.

 

Treasury Stock Transaction

 

Effective January 26, 2012 two of our founders, including our former Chief Executive Officer, Mr. Larry Griffin, severed their ties with the Company upon execution of a settlement agreement with us.  At the time of their departure from the Company, each of them returned 525,000 shares (1,050,000 total) of common stock to the Company for cancellation to assist the Company and provide for a better capitalization to all the investors, and sold their remaining shares to other private individuals with no proceeds going to the Company.  The settlement agreement did not provide for payment by us or the founders. 

 

Stock Options

 

 

Number of

Options

Weighted

Average

Exercise Price

Weighted

Average

Remaining Life

(Years)

Balance, December 31, 2011

300,000

$ 2.00

 

Granted

872,000

$ 2.00

 

Exercised

(150,000)

$ 2.00

 

Cancelled

--

$ --

 

Balance, December 31, 2012

1,022,000

$ 2.00

4.30

Granted

410,000

$ 2.76

 

Exercised

--

$ --

 

Cancelled

(112,000)

$ 2.00

 

Balance, December 31, 2013

1,320,000

$ 2.23

3.44

Exercisable, December 31, 2012

710,000

$ 2.00

 

Exercisable, December 31, 2013

845,000

$ 2.04

 

 

The fair value of each stock option granted was estimated on the date of grant using the Black Scholes option pricing model with the following assumptions:

 

 

 

December 31, 2013

 

December 31, 2012

Risk-free interest rate range

 

0.11% - 1.55%

 

0.62% - 0.91%

Expected life

 

5.0 Years

 

5.0 Years

Vesting Period

 

0 - 4 Years

 

0 - 4 Years

Expected volatility

 

39%

 

39%

Expected dividend

 

-

 

-

Fair value range of options at grant date

 

$1.008 - $1.089

 

$0.675 - $0.705

 

Significant assumptions utilized in determining the fair value of our stock options included the volatility rate, estimated term of the options, risk-free interest rate and forfeiture rate.  In order to estimate the volatility rate at each issuance date, given that the Company has not established a historical volatility rate as it has minimal trading volume since we began trading in October 2013, management reviewed volatility rates for a number of companies with similar manufacturing operations to arrive at an estimated volatility rate for each option grant.  The term of the options was assumed to be five years, which is the contractual term of the options.  The risk-free interest rate was determined utilizing the treasury rate with a maturity equal to the estimated term of the option grant.  Finally, management assumed a zero forfeiture rate as the options granted were either fully-vested upon the date of grant or had relatively short vesting periods.  As such, management does not currently believe that any of the options granted will be forfeited.  We will monitor actual forfeiture rates, if any, and make any appropriate adjustments necessary to our forfeiture rate in the future.

 

For the years ended December 31, 2013 and 2012, the Company recorded stock-based compensation expense of $216,083 and $456,998, respectively.

 

As of December 31, 2013 and 2012 there was $404,006 and $181,455, respectively, of unrecognized compensation expense related to the issuance of the stock options.

 

Performance Stock Options

 

There were no performance Stock options granted during the year ended December 31, 2013.

 

 

Number of

Options

 

Weighted

Average

Exercise

Price

Balance, December 31, 2011

1,400,000

 

$ 0.06

Granted

40,000

 

$ 2.00

Exercised

--

 

$ -

Cancelled

--

 

$ -

Balance, December 31, 2013 and December 31, 2012

1,440,000

 

$ 0.11

Exercisable, December 31, 2013 and December 31, 2012

40,000

 

$ 2.00

 

See Note 4 for further discussion of the performance options.

 

Warrants

 

The Company issued warrants in connection with the Series D unit offering discussed above. Each unit consisted of one share of Series D Preferred Stock and one-half warrant, with each whole warrant exercisable at $3.00 per share and grants the right to purchase a share of the Company’s common stock. The warrants are exercisable by the holders through and including October 1, 2014.

 

 

Number of

Warrants

Weighted

Average

Exercise

Price

Weighted

Average

Remaining

Life (Years)

Granted

363,824

$ 3.00

 

Exercised

-

$      -

 

Cancelled

-

$      -

 

Balance, December 31, 2013

363,824

$ 3.00

0.75